Tumor Purity-Related Genes for Predicting the Prognosis and Drug Sensitivity of DLBCL Patients
View ORCID ProfileZhenbang Ye, Ning Huang, Yongliang Fu, Rongle Tian, Liming Wang, Wenting Huang
doi: https://doi.org/10.1101/2023.10.04.23296534
Zhenbang Ye
1Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Ning Huang
2Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Yongliang Fu
1Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Rongle Tian
1Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Liming Wang
2Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Wenting Huang
1Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
3Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China
Data Availability
The GEO datasets can be obtained from https://www.ncbi.nlm.nih.gov/gds/?term=. Due to the nature of this study, the data of CHCAMS cohort can be accessed from Dr. Wenting Huang upon reasonable request.
Posted March 26, 2024.
Tumor Purity-Related Genes for Predicting the Prognosis and Drug Sensitivity of DLBCL Patients
Zhenbang Ye, Ning Huang, Yongliang Fu, Rongle Tian, Liming Wang, Wenting Huang
medRxiv 2023.10.04.23296534; doi: https://doi.org/10.1101/2023.10.04.23296534
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (705)
- Anesthesia (197)
- Cardiovascular Medicine (2885)
- Dermatology (247)
- Emergency Medicine (433)
- Epidemiology (12624)
- Forensic Medicine (10)
- Gastroenterology (813)
- Genetic and Genomic Medicine (4485)
- Geriatric Medicine (410)
- Health Economics (717)
- Health Informatics (2869)
- Health Policy (1059)
- Hematology (379)
- HIV/AIDS (912)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4253)
- Nursing (228)
- Nutrition (622)
- Oncology (2227)
- Ophthalmology (634)
- Orthopedics (255)
- Otolaryngology (323)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1182)
- Primary Care Research (489)
- Public and Global Health (6832)
- Radiology and Imaging (1503)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (376)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)